Highlights

  • Move came during the court's hearing of petitions filed by the Indian Medical Association (IMA)
  • The court expressed grave concern over misleading medical advertisements

Latest news

iQOO Buds Review: Monster Battery and Serious Gaming Chops for under ₹2,000 

iQOO Buds Review: Monster Battery and Serious Gaming Chops for under ₹2,000 

Repo rate today at 5.25%: how long an RBI decision takes to reach your home loan interest rate

Repo rate today at 5.25%: how long an RBI decision takes to reach your home loan interest rate

CMF Buds Neo Review: 35dB ANC, 52-Hour Battery and Incredible Value

CMF Buds Neo Review: 35dB ANC, 52-Hour Battery and Incredible Value

iQOO Z11 Review: A Balanced Mid-Range Powerhouse

iQOO Z11 Review: A Balanced Mid-Range Powerhouse

Samsung Galaxy Watch 9 Review: Familiar, Faster And Better Where It Matters

Samsung Galaxy Watch 9 Review: Familiar, Faster And Better Where It Matters

Samsung Galaxy Watch Ultra2 Review: A Smarter, Tougher and Longer-Lasting Ultra

Samsung Galaxy Watch Ultra2 Review: A Smarter, Tougher and Longer-Lasting Ultra

Gabit Smart Ring Review: A Better Way To Track Your Health? 

Gabit Smart Ring Review: A Better Way To Track Your Health? 

Xiaomi Power Bank 5i 20000 67W Review: A Powerful Travel Companion

Xiaomi Power Bank 5i 20000 67W Review: A Powerful Travel Companion

Supreme Court’s stern warning to Patanjali over misleading ads

Baba Ramdev's Patanjali Ayurveda faces Supreme Court ire over false cure claims

Supreme Court’s stern warning to Patanjali over misleading ads

The Supreme Court of India delivered a stringent warning to Patanjali Ayurveda, co-founded by Baba Ramdev, demanding an immediate halt to "misleading advertisements." Justices Ahsanuddin Amanullah and Prashant Kumar Mishra presiding over the case affirmed that any product making false cure claims would be slapped with a staggering ₹1 crore penalty.

This admonishment came during the court's hearing of petitions filed by the Indian Medical Association (IMA). Justice Amanullah emphasized, "All such false and misleading advertisements of Patanjali Ayurveda have to stop immediately." The court expressed grave concern over misleading medical advertisements and warned of severe repercussions for any breach.

The bench clarified its stance, indicating a desire not to escalate the matter into an "Allopathy v. Ayurveda" debate but aimed to address the menace of misleading medical advertising. Stressing the gravity of the issue, the court directed the Union Government to devise effective solutions following consultations. The case is set to reconvene on February 5, 2024, for further deliberations.

Also read/watch - Byju's denies reports of a ₹9,000 crore FEMA violation notice from ED

The IMA's petition also accused Patanjali of fueling vaccine hesitancy by spreading misinformation about COVID-19 vaccines. Additionally, Ramdev faced criticism for allegedly mocking citizens seeking oxygen cylinders during the second wave.

Earlier in February, Ramdev sparked controversy by suggesting a surge in cancer cases post the COVID-19 pandemic. Speaking at a Patanjali Yog Samiti yoga camp in Goa, he claimed, "Cancer has increased a lot...People have lost their eyesight, their sense of hearing..." Goa Chief Minister Pramod Sawant shared the stage with Ramdev.

Subsequently, Ramdev sought protection in the Supreme Court after facing criminal charges across multiple states for his contentious statements

ADVERTISEMENT

Up Next

Supreme Court’s stern warning to Patanjali over misleading ads

Supreme Court’s stern warning to Patanjali over misleading ads

Repo rate today at 5.25%: how long an RBI decision takes to reach your home loan interest rate

Repo rate today at 5.25%: how long an RBI decision takes to reach your home loan interest rate

Step-by-step guide to apply for a mortgage loan online with minimal documentation

Step-by-step guide to apply for a mortgage loan online with minimal documentation

Honda Activa 6G: Everything You Need to Know Before Buying

Honda Activa 6G: Everything You Need to Know Before Buying

How much does a ULIP plan really cost? A break-down of all charges

How much does a ULIP plan really cost? A break-down of all charges

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

Centre plans to borrow Rs 8.20 lakh cr from market in first half of FY27

ADVERTISEMENT

editorji-whatsApp

More videos

Reliance denies buying Iranian oil amid US sanctions waiver

Reliance denies buying Iranian oil amid US sanctions waiver

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

Premium petrol price up Rs 2, industrial diesel up Rs 22; no change in normal petrol, diesel rates

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

India's GDP expected to register over 8 pc growth in Sep-Dec: Report

Govt announces seven measures to help boost exports

Govt announces seven measures to help boost exports

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI keeps interest rates on hold after US trade deal boosts outlook

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI proposes to compensate customers up to Rs 25,000 loss due to fraud

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI raises GDP growth projection of Q1, Q2 of FY27

RBI pauses rate cuts, retains interest rate at 5.25 pc

RBI pauses rate cuts, retains interest rate at 5.25 pc

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Rupee jumps 122 paise to close at 90.27 against US dollar on India-US trade deal

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

Stock markets cheer India-US trade deal: Sensex, Nifty surge 2.5 pc

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.